These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7699901)
1. [The role of interferon-alpha in the treatment of multiple myeloma]. Koyama S Nihon Rinsho; 1995 Mar; 53(3):658-63. PubMed ID: 7699901 [TBL] [Abstract][Full Text] [Related]
4. The role of interferon-alpha in the management of myelomatosis. Avvisati G; Mandelli F Hematol Oncol Clin North Am; 1992 Apr; 6(2):395-405. PubMed ID: 1582981 [TBL] [Abstract][Full Text] [Related]
5. [New protocols for myeloma chemotherapy plus IFN alpha]. Kitani T Rinsho Ketsueki; 1993 Apr; 34(4):455-9. PubMed ID: 8510333 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy of M2-protocol and interferon-alpha as remission induction in refractory multiple myeloma. Shimamoto Y; Matsuzaki M; Ono K; Sano M; Yamaguchi M Haematologia (Budap); 1991; 24(1):9-11. PubMed ID: 1813363 [TBL] [Abstract][Full Text] [Related]
7. [Progress in the treatment of multiple myeloma]. Wada M; Mizoguchi H Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160 [TBL] [Abstract][Full Text] [Related]
8. [Interferon therapy in multiple myeloma]. Micksche M Wien Med Wochenschr; 1993; 143(16-17):425-8. PubMed ID: 8273366 [TBL] [Abstract][Full Text] [Related]
10. Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment. Powles R; Raje N; Milan S; Millar B; Shepherd V; Mehta J; Singhal S; Kulkarni S; Viner C; Gore M; Cunningham D; Treleaven J Bone Marrow Transplant; 1997 Sep; 20(6):435-43. PubMed ID: 9313875 [TBL] [Abstract][Full Text] [Related]
11. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486. Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521 [TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and therapy of multiple myeloma: current aspects]. Betticher DC; Cerny T; Fey MF Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848 [TBL] [Abstract][Full Text] [Related]
14. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol]. Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962 [TBL] [Abstract][Full Text] [Related]
15. alpha-Interferon for remission maintenance: preliminary report on the Southwest Oncology Group Study. Salmon SE; Beckord J; Pugh RP; Barlogie B; Crowley J Semin Oncol; 1991 Oct; 18(5 Suppl 7):33-6. PubMed ID: 1948127 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of multiple myeloma--present status and perspectives]. Robak T Acta Haematol Pol; 1996; 27(1):5-14. PubMed ID: 8629444 [TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myeloma. Musto P; Sajeva MR; Sanpaolo G; D'Arena G; Scalzulli PR; Carotenuto M Haematologica; 1997; 82(3):354-6. PubMed ID: 9234591 [TBL] [Abstract][Full Text] [Related]
18. [Clinical trial of alpha-interferon (human lymphoblastoid interferon) in combination with VCAP chemotherapy in multiple myeloma]. Umeda M; Shirai T; Tsukahara T; Kaneko H; Yamauchi M; Arai N; Kosuge T; Kato M; Shikoshi K; Anno S Rinsho Ketsueki; 1991 Jun; 32(6):669-74. PubMed ID: 1890744 [TBL] [Abstract][Full Text] [Related]
19. The role of alpha-interferon in multiple myeloma. Peest D Pathol Biol (Paris); 1999 Feb; 47(2):172-7. PubMed ID: 10192884 [TBL] [Abstract][Full Text] [Related]
20. [Current and future approaches to therapy for multiple myeloma]. Nara N Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]